Your new post is loading...
ImmunID has developed immune tests to measure T cell diversity and B cell diversity, in a quantitative and exhaustive way. These tests use a patented multi-N-plex® quantitative PCR technology to detect and characterize V-J rearrangements of the T and B cell receptor at the genomic DNA level. The assay allows the simultaneous detection of several V–J rearrangements in the same reaction and covers 100% of the possible combinatorial rearrangements (for more information on immunogenetics, please refer to the International ImMunoGeneTics Information System).
Immune profiling on a platform compatible with clinical routine requirements
ImmunID’s proprietary testing platform combines quantitative PCR, microfluidics and bioinformatics. ImmunID’s tests allow to translate the complexity of the immune repertoire into easily-visualized and interpretable data.
Immune testing is performed on ImmunID’s platform in 3 main steps:
Preanalytical samples preparation : genomic DNA extraction and Quality ControlsQuantitative multi-N-plex® Polymerase Chain Reaction and amplicons detection by microfluidicsData analysis by our proprietary Constel ID® software
Via Krishan Maggon
ImmunID is the first company able to provide a standardized analysis of the immune statusthrough the evaluation of immune diversity with a test compatible with clinical research and, in the future, with medical routine.
ImmunID spun out of the laboratories of the CEA in 2005 in Grenoble, France. The CEA is a French government-funded technological research organization, in which the two co-founders, Nicolas Pasqual and Sébastien Weisbuch, were working as scientists. Both truly believed in the value and potential of the immune profiling technologies they had been developing, and decided to create ImmunID. Just a few months after the inception of the company, Nadia Plantier and Jean-Francois Mouret joined Nicolas and Sébastien, in order to further develop these game-changing technologies and to bring them to patients and physicians, through a simple, reliable and clinically meaningful immune status test.
unfortunately not yet applicable in immune monitoring assays in franch university hospitals